Back to results
US 7,465,795 B2Granted
Compounds and uses thereof
AssigneeAstraZeneca AB
InventorsMarc J. Chapdelaine, Cyrus J. Ohnmacht, Christopher Becker, Hui-Fang Chang, Bruce T. Dembofsky
Life of this patent
Estimating the term…
Abstract
This invention relates to novel compounds having the structural formula I below: and their pharmaceutically acceptable salts, tautomers or in vivo-hydrolysable precursors, compositions and methods of use thereof. These novel compounds provide a treatment or prophylaxis of anxiety disorders, cognitive disorders, and/or mood disorders.
Claims1
A compound selected from 4-amino-8-(2-fluoro-6-methoxy-phenyl)-N-propylcinnoline-3-carboxamide and pharmaceutically acceptable salts thereof.
Dependencies are inferred from the claim text.